Nutriband Inc. – NASDAQ:NTRBW
Nutriband stock price today
Nutriband stock price monthly change
Nutriband stock price quarterly change
Nutriband stock price yearly change
Nutriband key metrics
Market Cap | 48.31M |
Enterprise value | 12.36M |
P/E | -3.8 |
EV/Sales | 6.04 |
EV/EBITDA | -2.00 |
Price/Sales | 7.33 |
Price/Book | 1.53 |
PEG ratio | 0.03 |
EPS | -0.77 |
Revenue | 2.01M |
EBITDA | -5.46M |
Income | -6.36M |
Revenue Q/Q | -14.34% |
Revenue Y/Y | -2.96% |
Profit margin | -321.56% |
Oper. margin | -321.27% |
Gross margin | 35.44% |
EBIT margin | -321.27% |
EBITDA margin | -270.8% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNutriband stock price history
Nutriband stock forecast
Nutriband financial statements
| Jul 2023 | 655.92K | -829.17K | -126.41% |
|---|---|---|---|
| Oct 2023 | 427.84K | -1.75M | -411.36% |
| Jan 2024 | 524.61K | -1.88M | -358.54% |
| Apr 2024 | 408.53K | -1.89M | -464.61% |
| Payout ratio | 0% |
|---|
| 2016 | |
|---|---|
| 2017 | |
| 2019 | |
| 2020 | |
| 2022 | 0.66% |
| Jul 2023 | 9872628 | 2.98M | 30.2% |
|---|---|---|---|
| Oct 2023 | 8523076 | 2.81M | 32.99% |
| Jan 2024 | 7517154 | 1.07M | 14.35% |
| Apr 2024 | 15154480 | 1.79M | 11.82% |
| Jul 2023 | -995.13K | 0 | 2.05M |
|---|---|---|---|
| Oct 2023 | -1.06M | 0 | -4.96K |
| Jan 2024 | -718.24K | -49.13K | -5.00K |
| Apr 2024 | -833.92K | -6.19K | 8.69M |
Nutriband alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 3 |
| Feb 2024 | 3 |
| Mar 2024 | 3 |
| Apr 2024 | 3 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
Nutriband other data
| Period | Buy | Sel |
|---|---|---|
| Feb 2022 | 6000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | MELNIK SERGUEI director, officer.. | Common Stock, par value $0.001 per share | 500 | $4.03 | $2,015 | ||
Purchase | MELNIK SERGUEI director, officer.. | Common Stock, par value $0.001 per share | 500 | $4.03 | $2,015 | ||
Purchase | MELNIK SERGUEI director, officer.. | Common Stock, par value $0.001 per share | 5,000 | $4.03 | $20,150 |
-
What's the price of Nutriband stock today?
One share of Nutriband stock can currently be purchased for approximately $1.4.
-
When is Nutriband's next earnings date?
Unfortunately, Nutriband's (NTRBW) next earnings date is currently unknown.
-
Does Nutriband pay dividends?
No, Nutriband does not pay dividends.
-
How much money does Nutriband make?
Nutriband has a market capitalization of 48.31M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 46.63% to 2.09M US dollars.
-
What is Nutriband's stock symbol?
Nutriband Inc. is traded on the NASDAQ under the ticker symbol "NTRBW".
-
What is Nutriband's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Nutriband?
Shares of Nutriband can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Nutriband have?
As Jul 2024, Nutriband employs 3 workers.
-
When Nutriband went public?
Nutriband Inc. is publicly traded company for more then 3 years since IPO on 1 Oct 2021.
-
What is Nutriband's official website?
The official website for Nutriband is nutriband.com.
-
Where are Nutriband's headquarters?
Nutriband is headquartered at 121 South Orange Avenue, Orlando, FL.
-
How can i contact Nutriband?
Nutriband's mailing address is 121 South Orange Avenue, Orlando, FL and company can be reached via phone at +40 73776695.
Nutriband company profile:
Nutriband Inc.
nutriband.comNASDAQ
3
Biotechnology
Healthcare
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
Orlando, FL 32801
CIK: 0001676047
ISIN: US67092M1255
CUSIP: 67092M125
